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ABSTRACT
Objectives In a previously published Delphi exercise 
the European Pediatric Dialysis Working Group (EPDWG) 
reported widely variable counteractive responses to 
COVID-19 during the first week of statutory public curfews 
in 12 European countries with case loads of 4–680 
infected patients per million. To better understand these 
wide variations, we assessed different factors affecting 
countermeasure implementation rates and applied the 
capability, opportunity, motivation model of behaviour to 
describe their determinants.
Design We undertook this international mixed methods 
study of increased depth and breadth to obtain more 
complete data and to better understand the resulting 
complex evidence.
Setting This study was conducted in 14 paediatric 
nephrology centres across 12 European countries during 
the COVID-19 pandemic.
Participants The 14 participants were paediatric 
nephrologists and EPDWG members from 12 European 
centres.
Main outcome measures 52 countermeasures clustered 
into eight response domains (access control, patient 
testing, personnel testing, personal protective equipment 
policy, patient cohorting, personnel cohorting, suspension 
of routine care, remote work) were categorised by 
implementation status, drivers (expert opinion, hospital 
regulations) and resource dependency. Governmental 
strictness and media attitude were independently 
assessed for each country and correlated with relevant 
countermeasure implementation factors.
Results Implementation rates varied widely among 
response domains (median 49.5%, range 20%–71%) and 
centres (median 46%, range 31%–62%). Case loads were 
insufficient to explain response rate variability. Increasing 
case loads resulted in shifts from expert opinion- based 
to hospital regulation- based decisions to implement 
additional countermeasures despite increased resource 
dependency. Higher governmental strictness and positive 
media attitude towards countermeasure implementation 
were associated with higher implementation rates.
Conclusions COVID-19 countermeasure implementation 
by paediatric tertiary care centres did not reflect case 
loads but rather reflected heterogeneity of local rules and 
of perceived resources. These data highlight the need of 
ongoing reassessment of current practices, facilitating 
rapid change in ‘institutional behavior’ in response to 
emerging evidence of countermeasure efficacy.
Strengths and limitations of this study
 ► This is the first study using a mixed methods ap-
proach to evaluate and better understand the most 
important drivers of behaviours conducive to coun-
teracting the COVID-19 pandemic during the first 
week of public curfews.
 ► To understand the generic mechanisms of our re-
sponses to COVID-19, the capability, opportunity, 
motivation model of behaviour allows for a more 
critical review and appraisal of current practices 
than standardised responses usually provided by 
policymakers and societal guidelines.
 ► Put into general context, these dynamic domains 
with manifold factors may provide some of the most 
important guiding principles but lack general com-
pleteness and might be rapidly outdated.
 ► Interpretation of the results of this study is limited by 
the small number of participating centres and mixed 
methods character of this study, wherefore statisti-
cal tests and their corresponding p values should be 
interpreted with caution.
 ► Although our results are representative for paedi-
atric dialysis, they may not represent to the same 
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INTRODUCTION
SARS- CoV-2- related disease (COVID-19) spread 
throughout Europe when minimal evidence was avail-
able to support efficacy of then available countermea-
sures.1–4 The European Pediatric Dialysis Working Group 
(EPDWG) conducted a Delphi exercise over 5 days during 
the first week of statutory public curfews in 13 paedi-
atric nephrology centres from 11 European countries5 
using ‘crowd intelligence’ to define countermeasures in 
several relevant response domains, and to assess their 
implementation rates.5 Whereas some countermeasures 
(replacement of routine visits by telephone calls) were 
widely implemented, others (asymptomatic staff member 
testing) were rarely implemented, and implementation 
rates varied widely among countermeasures and centres.5 
This heterogeneity may have reflected country- specific 
infection rates and pandemic stage- dependent measures 
to decrease infection rates. However, the mechanisms 
underlying COVID-19 countermeasure implementation 
by individual centres were not studied.
The capability, opportunity, motivation model 
of behaviour (COM- B)6 describes determinants of 
behaviour,7 including capability (physical and psycholog-
ical capacity to engage in an activity, such as knowledge 
and skills), opportunity (physical and social factors outside 
the individual that permit or prevent a certain behaviour) 
and motivation (brain processes that energise and direct 
behaviour).6 In 2011, the behaviour change wheel (BCW) 
was added to the COM- B to distinguish between interven-
tions (activities aimed at changing behaviour) and policies 
(actions of responsible authorities or the government that 
enable interventions, respectively change of behaviour).6
In this study, in order to explain the huge response vari-
ability among these tertiary care centres, we explored factors 
affecting practice behaviour changes for the implementation 
of countermeasures in each paediatric dialysis centre. We 
therefore used the COM- B and the BCW to map and concep-
tualise the determinants of behavioural change in paediatric 
tertiary care centres relating to COVID-19 countermeasure 
implementation rates during the first week of statutory public 
curfews in Europe. Such insights may permit improved 
management of impending COVID-19 resurgence(s) and 
of future pandemic events, especially on how to implement 
evidence- based changes in practice to optimise management 
of complex healthcare interventions.
MATERIALS AND METHODS
The methodology of the Delphi exercise conducted 
among the EPDWG in March 2020 was recently described.5 
This follow- up study examines 14 EPDWG centres from 
12 countries (Austria, Belgium, Czech Republic, France, 
Germany, Greece, Italy, Lithuania, Poland, Spain, Turkey 
and the UK). Exploration of complex and pluralistic 
contexts, such as cross- national studies, requires a 
comprehensive research approach. The mixed methods 
design is an ideal means to gain both depth and breadth. 
It allows the researcher to gain a better understanding 
of the research problem by yielding more complete 
evidence.8–10 Therefore, individual sets of 52 countermea-
sures (see ref 5) were mailed to each centre to validate 
countermeasure implementation rates on 20 March, and 
to assess altered rates on 3 April 2020. Participants were 
asked whether implementation decisions concerning 
individual countermeasures were based on expert 
opinion and/or hospital regulations and/or resource 
availability. Country- specific case loads from the Euro-
pean Centre for Disease Prevention and Control11 were 
calculated as case number per million (from Eurostat12). 
Pandemic phase was expressed as binary logarithm of 
case loads per million, since exponential case doubling 
times in the EPDWG countries (~2 days at that time) tran-
sitioned gradually to a logistic function.
Behaviour change determinants
COM- B and BCW components were mapped to concepts 
derived from anonymised EPDWG experts’ initial open 
email replies to the first Delphi exercise.5 Mapping 
was conducted by component definitions and experts’ 
wording using modified meaning condensation analysis 
to aggregate experts’ statements in terms of underlying 
concepts (figure 1). For example, the email statement 
‘Timely recipient testing should be feasible in our center’ was 
mapped to Opportunity (physical) and to BCW policy ‘envi-
ronmental/social planning’, whereas the statement ‘I read a 
lot about this, but to my knowledge we cannot draw any firm 
conclusions’ was assigned to Capability (psychological) and to 
BCW policy ‘guidelines’ (figure 1C). To ensure accuracy 
and rigour, initial mapping performed by one researcher 
(FE) was independently reviewed by a second senior 
qualitative researcher (VR). In cases of disagreement, 
consensus was achieved through discussion.
Governmental strictness
Country- specific online news agencies and governmental 
information websites were searched for governmental 
interventions in response to COVID-19. Relative frequen-
cies of 23 defined governmental interventions to achieve 
‘social distancing’ were combined to yield a governmental 
strictness score (online supplemental table 1). Inter-
ventions included restriction of free public movement, 
restriction of hospital access, restriction of prison access, 
recommended or mandatory teleworking, requirements 
for adequate mouth and nose coverage in public, closure 
of parks and playgrounds, closure of governmental facil-
ities (eg, schools, universities), closure of mass events, 
recommendation to limit gatherings to five people, 
prohibition of gatherings exceeding five people, police 
surveillance, closure of non- essential businesses, closure 
of restaurants, local quarantine, nationwide quarantine, 
selective border closure, complete border closure, state 
of emergency, vacation ban for healthcare professionals, 
implementation of telemedicine, export and sales ban 
on all FFP3- type respirators and selected medications, 
ban on minors leaving home unaccompanied by a legal 
guardian and censorship of medical personnel.
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Legend:
Figure 1 (A) The conceptual framework of COM- B is based on interaction between capability, opportunity and motivation 
to change behaviour. To implement countermeasures, expert opinion and/or hospital rules balance resource dependency of 
a given measure with the pressure to counteract COVID-19 during the progressive pandemic phases. (B) Factors relevant 
in implementing countermeasures and their interactions structured according to COM- B and the behaviour change wheel 
(positively correlated, green arrows; negatively correlated, red drumsticks). (C) Behaviour change wheel within the COM- B 
model displaying the five policy measures, with their respective concepts, influencing behaviour change as implementation of 
countermeasures according to the European Pediatric Dialysis Working Group (EPDWG).
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Media attitude
Cover page articles during the week of 20 March 2020 
from the three widest circulating newspapers in each 
EPDWG country and text blocks containing COVID-19- 
related news and/or opinion pieces were manually clas-
sified. Transcribed, translated and anonymised excerpts 
from the selected articles were rated by participants (n=5) 
for positivity of reporting attitude on COVID-19 counter-
measures on a scale from 1 (lowest) to 5 (highest). 
Excerpts were uniformly formatted without country iden-
tifiers. Mean values yielded a country- specific media atti-
tude score (online supplemental table 1).
Data analysis and statistics
Data were clustered into eight response domains (access 
control, patient testing, testing healthcare personnel 
(HCP), personal protective equipment (PPE) policy, 
patient cohorting, HCP cohorting, suspension of routine 
care, remote work) and visualised as implementation 
rates and their rates of change (online supplemental 
figure 1). Response rates (%) were calculated as numbers 
of implemented countermeasures divided by numbers of 
total identified countermeasures for 20 March and 3 April 
2020. Resource dependency (%) for 20 March 2020 was 
calculated as numbers of decisions for which resources 
were decisive for implementation, divided by numbers of 
total identified countermeasures.
Expert decisions and hospital authority decisions were 
expressed as the hospital authority decisions to expert 


















The H/E ratio expresses the degree to which response 
rates are influenced by hospital authority decisions 
(resulting in positive values to +1) or by expert decisions 
(resulting in negative values to −1), with the balanced 
H/E ratio of zero reflecting equivalent contributions of 
hospital authority and experts’ decisions.
Each of these variables was calculated (1) on the domain 
level, as mean for each domain across all centres, and (2) 
on the centre level, as mean for each centre across all 
domains. Data were analysed with descriptive statistics 
using scatter plot matrices, bar plots, histograms and heat 
maps. Kendall’s tau correlation analysis was conducted 
within a correlation matrix for each dependent and inde-
pendent variable on each level. Correction for multiple 
testing was not performed, reflecting the exploratory 
character of this analysis. For Kendall’s tau, correlation 
analysis between response rates and pandemic phase 
outliers was omitted post hoc (high response despite low 
case load, or relatively low responses despite highest case 
loads).
RESULTS
Implementation of individual counteractive measures 
varied widely among response domains and centres in 
the cross- sectional analysis of 20 March 2020. Domain 
response rates ranged from 20% (28/140) to 71% 
(59/84); median 49.5%. Centre response rates ranged 
from 31% (16/52) to 62% (32/52); median 46%. Reas-
sessment of response rates on 3 April demonstrated 
increased countermeasure implementation, particularly 
in centres with lower initial response rates (‘catch- up 
implementation’).
‘Snapshot’ of implemented COVID-19 countermeasures (20 
March 2020)
Centre response rates or individual countermeasure 
response rates correlated weakly with centre case loads. 
Figure 2 demonstrates that centres at both ends of the 
pandemic phase spectrum markedly deviated from the 
assumption of correlation. Although overall correlations 
between centre responses and pandemic phase were 
statistically significant, country/centre- specific case loads 
correlated with implemented countermeasures only after 
outlier exclusion (table 1).
Policy measures influencing implementation of 
countermeasures per BCW
Five of seven BCW- defined policy measures6 were reported 
as reasons for behaviour change in the clinical setting 
(figure 1C). As expected, ‘regulation’ by employers 
(establishing rules of principles of behaviour) and/or 
governmental ‘legislation’ were important reasons for 
behavioural changes at the centres. However, information 
from mass media (‘communication’), missing ‘guidelines’ 
and ‘environmental/social’-related restrictions were 
equally often determinative for change in behavioural 
patterns. ‘Fiscal measures’ and ‘service provision’ were 
not mentioned as influencing behavioural changes. Mass 
media information indicated increasing pressure from 
growing case loads in the EPDWG centres (‘commu-
nication’), corresponding to correlation of pandemic 
phase with average countermeasure implementation 
rates (table 1). Respondents often noted that recom-
mendations (‘guidelines’) for clinical decision- making 
remained lacking, likely explaining why rules and prin-
ciples established by hospital management (‘regulation’) 
contributed more as important drivers for implementa-
tion than did ‘guidelines’ (table 1). Growing mass media 
pressure (‘communication’) in most centres resulted in 
a pandemic phase- dependent shift from expert opinion 
(missing ‘guidelines’) to hospital- based ‘regulations’ 
(table 1).
Resource dependency was a major inhibitor of counter-
measure implementation (‘environmental/social’ restric-
tions). Estimated resource dependency of eight individual 
measures correlated negatively with their implementation 
rates at the domain level (figure 3, table 1). Increasing 
resource dependency associated with an increasing ratio 
of hospital rules (‘regulations’) over expert opinion 
(missing ‘guidelines’) as a driver of countermeasure 
implementation (table 1). Interestingly, implementa-
tion rates for countermeasures of comparable resource 
P
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dependency (‘environmental/social’ restrictions) 
increased in direct proportion to the H/E ratio (‘regu-
lations’; compare, for example, ‘Suspension of Routine 
Care/Remote Work’ with comparably low- resource 
dependency and ‘Testing HCP/Patients’ with comparably 
high- resource dependency; figure 3B, figure 4).
Longitudinal assessment of ‘catch-up’ implementation of 
COVID-19 countermeasures
The above cross- sectional assessment describes associations 
between individual factors and countermeasure imple-
mentation rates in different centres/countries at different 
pandemic phases. Longitudinal changes in countermeasure 
implementation rates were assessed by another survey on 
3 April 2020 and plotted as a function of pandemic phase. 
Figures 3A and 4A show that pandemic progression resulted 
in globally increased rates of countermeasure implementa-
tion from 20 March to 3 April in almost all centres (table 1). 
At the centre level, mean changes of response rates were 
negatively influenced by cumulative local perception of 
resource dependency on 20 March (=‘resource awareness’, 
perceived ‘costs’; table 1). However, ‘catch- up implementa-
tion’ of counteractive measures from 20 March to 3 April 
positively correlated with higher H/E ratio (between hospital 
rule and expert opinion as drivers), and with resource depen-
dency of particular measures (table 1). Thus, growing pres-
sures of increased country- specific case loads increased local 
implementation of hospital rules, thereby overcoming the 
initially inhibitory effects of locally perceived resource depen-
dency for these measures in a centre- specific way.
Role of country-specific, non-medical influencers on 
countermeasure implementation
Centre- specific patterns of longitudinal changes suggest 
that local countermeasure implementation rates repre-
sent a balance of local influences only poorly modulated 
by global medical evidence, allowing study of the influ-
ence of non- medical drivers such as media and govern-
ment. Media attitude (online supplemental table 1) 
shows scores for implementation of COVID-19 counter-
measures in the 11 EPDWG countries. Cover page arti-
cles from the three widest circulation newspapers during 
the week of 20 March each contained >75% of COVID-
19- related text. Media attitude was only weakly associated 
with centre response rates (table 1). However, centres 
in countries with higher media attitude scores demon-
strated significantly lower ratios of hospital rules over 
expert opinion (table 1), in turn associated with higher 
implementation rates and catch- up (table 1). Indeed, 
the two centres with the highest media attitude scores 
demonstrated the highest response rates. Online supple-
mental table 1 also shows governmental strictness scores 
of the EPDWG countries. As for media attitude, govern-
mental strictness associated only weakly with response 
HCP Cohorting Suspension of Routine Care Remote work
Testing HCP PPE Policy Patient Cohorting
Overall Center Response Rate Access Control Patient Testing











































Figure 2 Response rates (calculated as relative frequencies) of implemented countermeasures for each centre (‘mean center 
response rate’, corresponding to the centre columns of online supplemental figure 1) and for each of the eight defined domains 
per centre, displayed as functions of pandemic phase (expressed as infected cases per million people) on 20 March 2020 (T1). 
Colours depicting centre response rates range from lowest (dark blue) to highest (dark red). Linear regression lines calculated 
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rates (table 1). However, centres in countries with higher 
governmental strictness scores demonstrated lower 
perceptions of resource dependency regarding counter-
measure implementation (table 1), in turn associated 
with higher implementation rates and catch- up imple-
mentation (table 1). Interestingly, positive media attitude 
(potentially enhancing motivation) paired with high 
governmental strictness (potentially reducing resource 
dependency) was found in the two countries with the 
highest response rates (at intermediate case load).
DISCUSSION
During the COVID-19 pandemic, the most important 
motivational driver of behaviours conducive to coun-
teracting the pandemic has been the magnitude of 
pandemic growth. In the absence of prior evidence, many 
interventions were rapidly executed on local, national 
and international levels with different degrees of coordi-
nation.1 4 13 The recent Delphi study from the EPDWG 
confirmed marked heterogeneity of COVID-19 counter-
measure implementation as of 20 March 2020, across 13 
paediatric nephrology centres in 11 European countries,5 
with case loads ranging from 4 to 680 infected patients 
per million (median 161 per million). This variability led 
us to hypothesise that growing pressures from increasing 
country- specific case loads were the main drivers for 
countermeasure implementation in our centres, and that 
differing numbers of infected patients might explain the 
heterogeneity in response rates among centres, consistent 
with general international trends amidst the COVID-19 
pandemic.5 14
However, the present study’s comparisons of centre case 
loads with mean centre responses or with mean response 
rates of individual measures found no close correlation. 
Thus, pandemic phase alone cannot explain the observed 
heterogeneity of COVID-19 countermeasure imple-
mentation rates across European centres. We therefore 
treated countermeasure implementation as a complex 
process with multiple influencers.6 15 In the conceptual 
framework of COM- B, countermeasure implementation 
rates likely represent the ‘capability’ (as ‘regulation’ and/
or ‘guideline’ policies) of their drivers (experts and/or 
hospital authorities) to allocate resources by opinion or 
rules, balancing pressure of the pandemic phase (‘moti-
vation’ as ‘communication’ policies) and availability 
of resources (‘opportunity’ as ‘environmental/social’ 
policies).
Complex interactions between these factors in the 
BCW (figure 1) might better explain observed heteroge-
neities of implementation rates among different centres 
and measures. In this context, increased pressure from 
pandemic progression shifted expert opinion- based 
Table 1 Statistical analysis of the COM- B model as applied to the EPDWG decisions
COM—variable Variable (B or COM) Kendall’s tau P value
Cross- sectional analysis
  Pandemic phase (case load) Implementation rate 0.23 <0.01
  Pandemic phase (case load)* Implementation rate* 0.77 <0.01
  Pandemic phase (case load) Hospital to expert ratio (centre) 0.24 <0.01
  Hospital to expert ratio (centre) Implementation rate 0.41 <0.01
  Hospital to expert ratio (domain) Implementation rate −0.36 <0.01
  Resource dependency (centre) Implementation rate 0.16 0.03
  Resource dependency (centre) Hospital to expert ratio (centre) 0.45 <0.01
  Pandemic phase (case load) Resource dependency (centre) 0.30 <0.01
  Resource dependency (domain) Hospital to expert ratio (domain) 0.47 <0.01
Longitudinal analysis
  Implementation rate Catch- up implementation −0.15 0.04
  Resource dependency (centre) Catch- up implementation −0.18 0.01
  Resource dependency (domain) Catch- up implementation 0.4 <0.01
  Hospital to expert ratio (domain) Catch- up implementation 0.47 <0.01
Influence of media attitude and governmental strictness
  Media attitude Implementation rate 0.17 0.02
  Media attitude Hospital to expert ratio (centre) −0.31 <0.01
  Governmental strictness Implementation rate 0.3 <0.01
  Governmental strictness Resource dependency (centre) −0.36 <0.01
*After omitting outliers (=high responses despite low case load or relatively low responses despite highest case loads).
B, behaviour change; COM, capability, opportunity, motivation; EPDWG, European Pediatric Dialysis Working Group.
P
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decisions towards more formal hospital rules, likely to 
overcome growing barriers to additional countermea-
sure implementation that in part reflected increasing 
awareness of growth in resource dependency. This might 
further reflect transfer of decisions from a personal 
individual level to systemic levels with increasing moral 
injury and mental health issues due to constrictions in 
provision of care caused by inadequate resources.16 From 
the perspective of children requiring long- term kidney 
replacement therapy (dialysis or kidney transplantation), 
examples of resource dependency include increased 
difficulties in accessing medical care and travelling to 
hospitals for regular kidney function tests, drug concen-
tration monitoring at specialised clinics and acquisition 
of medical supplies such as peritoneal dialysis fluids 
and equipment.17 In a February 2020 Chinese survey 
of caretakers of children requiring long- term kidney 
replacement therapy in the midst of the pandemic, 
these resource- dependent factors were thought by nearly 
80% of participants to negatively affect their children’s 
treatment, with one- third perceiving the effect as severe 
or extremely severe.17 EPDWG centre implementation 
rates of COVID-19 countermeasures, when regarded 
as changes of ‘institutional behavior’, thus reflected 
the ability of drivers at each centre to overcome local 


































































Figure 3 (A) Centre- specific ratios of hospital rules (red) 
to expert opinion (blue) (H/E ratio) driving countermeasure 
implementation for each of the 13 European Pediatric Dialysis 
Working Group (EPDWG) centres as a function of infected 
patient case load (log2 of infected cases per million people), 
a measure of pandemic phase on 20 March 2020 (T1). (B) 
Domain response rates (implemented countermeasures 
per domain as % of total) as a function of countermeasure 
resource dependency (mean of all estimates from each 
centre for each individual domain) for each of the eight 
countermeasure domains and their drivers (red, hospital 
rules; green, expert opinion) on 20 March 2020 (T1). Higher 
implementation rates of countermeasures with comparable 
resource dependency often correlated with higher hospital/
expert driver ratio (compare ‘Testing HCP’ to ’Patient Testing‘ 
as opposed to comparison of ’Suspension of Routine Care‘ 










































































Figure 4 (A) Response rate dynamics were plotted for 
each centre versus dynamics of pandemic phase (log2- 
transformed cases per million people) during the period of 
20 March to 3 April 2020 (DELTA = difference of response 
rates/log2- transformed cases per million people between 
the two points in time). (B) Changes in response rates during 
the period of 20 March to 3 April 2020 (DELTA = difference 
of response rates/domain H/E- Ratios between the two 
points in time) for each countermeasure domain were plotted 
against the average domain- specific hospital to expert ratio. 
Drivers for implementation are quantitated as relative domain 
resource dependency from low (green) to high (red). HCP, 
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perception of growing global medical need, led to diverse 
local rules and heterogeneous responses. Longitudinal 
assessment of countermeasure implementation from 20 
March to 3 April supported the hypothesis that pressure 
from growing country- specific case loads increased local 
implementation of hospital rules, overcoming the initially 
inhibitory effects of locally perceived resource depen-
dency of these measures, particularly measures with lower 
initial response rates. Initial inhibitory effects of locally 
perceived resource dependency might have diminished 
with the passage of time as medical supply deliveries and 
medical resource mobilisation have accelerated. These 
supplies are essential to carry out measures for pandemic 
control, protection of healthcare workers and mitiga-
tion of the severity of patient outcomes.18 Ordinarily, a 
shared body of scientific evidence (‘what is right’) under-
lies consensus procedures to harmonise ‘institutional 
behavior’ in response to medical challenges. Evidence- 
based medicine uses the best available evidence to help 
provide an optimal basis for decision- making according to 
individual circumstances and values.19 However, whereas 
COVID-19 countermeasure implementation rates 
increased at almost all EPDWG centres, overall response 
patterns among centres with similar case loads or at similar 
pandemic phase did not converge. Despite the pressure 
of pandemic progression, individual within- centre drivers 
appeared influenced by different perceptions of this pres-
sure and by different local resource dependencies (and/
or awareness of those dependencies). This suggests other 
centre- specific and/or country- specific factors, beyond 
pandemic phase progression, that significantly influ-
ence countermeasure implementation. The COM- B and 
BCW models also allow systematic analysis of drivers for 
different behaviours and interventions on all levels, from 
individuals to national governments and civil societies.
Our analysis identified the non- medical influencers, 
media attitude and governmental strictness as important 
determinants of EPDWG centre responses to COVID-19 
which might foster effective implementation of other 
medically relevant measures.20 Governmental inter-
ventions, in particular those aimed at social distancing, 
were recognised early in China as the most effective 
non- medical tool to ‘flatten the curve’ of the pandemic 
in several observations.1 13 21 Similar interventions, 
ranging from banning large events to strict curfews, were 
implemented to varying degrees in European countries 
during the week of 20 March. Our study quantified these 
interventions and found that higher ‘Governmental 
Strictness’ correlated with increased centre responses, 
associated with reduced perception of resource depen-
dency (‘resource/cost awareness’) of countermeasure 
implementation. Media dissemination of information 
can be incorporated in the COM- B and BCW models as 
a motivational driver for behaviour and decision- making 
on all social levels.20 This pertains especially to European 
countries attempting to contain the pandemic to the 
degree achieved in China, but in settings where govern-
mental strictness effects on social distancing depend 
more on individual decisions and actions.1 Furthermore, 
important obstacles opposing a comprehensive European 
response to COVID-19 are being exposed, despite high 
level of political commitment.22 During the week of 20 
March, the three widest circulation newspapers in each 
participating European country covered COVID-19 with 
>75% of front page text. Centres in countries with more 
positive media attitude towards governmental strictness 
(based on front page articles) also demonstrated higher 
response rates, associated with higher perception of 
importance of expert opinion as driver for countermea-
sure implementation. This is in line with a Chinese study 
exploring new and traditional media use amidst the begin-
nings of the COVID-19 outbreak.23 Chao et al found that 
new media use with heavier engagement was associated 
with negative psychological outcomes, whereas viewings 
of heroic acts, speeches from experts and knowledge of 
the disease and prevention were associated with positive 
psychological impact. They conclude that timely public 
health communication from official sources might be 
beneficial in terms of general psychological health.23 The 
rapidly evolving shared knowledge base and emerging 
‘best practices’ for counteracting COVID-19 in the Euro-
pean context allowed our study on EPDWG centre prac-
tice patterns, using COM- B and BCW models to describe 
behavioural drivers, to serve as a case study of institutional 
‘behavioral changes’ under high pressure with insuffi-
cient available information. Under such conditions, we 
might expect that skills (but not knowledge) and tactics 
(but not strategy) will guide an individual’s decisions and 
(measurable) actions. The same held true at the institu-
tional level where, for example, varied initial policies on 
PPE and testing material led to nationwide export bans, 
prioritising local demand and production.3 Furthermore, 
differences in testing strategy inherent to differences 
in commercially available laboratory tests, especially 
those failing to detect low- level immune responses to 
SARS- CoV-2 in asymptomatic or mildly affected subjects, 
as well as those indicating false- positive results,24 might 
complicate decision guidance through other factors. 
Such mechanisms and interdependencies detected by 
our targeted statistical approach might increase under-
standing of still heterogeneous response patterns among 
countries with similar infection rates. This is in line with 
most countries having responded to this acute crisis 
with different tactics, often borrowed from non- medical 
sectors, in order to reduce transmission, increase local 
resources and contain medical, economical and other 
public threats accompanying this pandemic—whether 
being successful or not.25 26
As COVID-19 countermeasure implementation in the 
European context was not based on ‘hard’ scientific 
evidence, none of the implemented local policies can be 
objectively judged from a medical viewpoint as ‘right’ or 
‘wrong’. At time of submission 6 months after the initial 
Delphi exercise, there remains no strong evidence on effi-
cacy of individual COVID-19 countermeasures pertaining 
to the European paediatric dialysis population. Recent 
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Chinese consensus guidelines27 mentioned neither 
suspension of routine care nor testing strategies (for HCP 
and patients), although these measures were advocated 
as important to COVID-19 control.28 The COVID-19 
outbreak in a German paediatric dialysis centre29 also 
highlights the importance of adequate testing, tracing 
and monitoring strategies for successful outbreak contain-
ment and prevention in the hospital setting. However, in 
the mean time, at least one comprehensive systematic 
review has been published. This meta- analysis supporting 
physical distancing and face mask use provides the best 
evidence yet available, given the body of literature gener-
ally lacking robust randomised trials.30
This exploratory work provides a framework containing 
the most important domains that emerged during the 
lockdown phase in paediatric dialysis centres across 
Europe. Put into general context, these domains may 
provide some of the most important guiding principles 
but lack general completeness and might be rapidly 
outdated. However, put into perspective of the BCW 
and the COM- B model, these domain sets present an 
important framework for regular and multilayered reas-
sessment by policymakers and clinicians to provide a basis 
for further decision- making and evolving awareness of 
possible limitations and subliminal influential factors.
As the results of this work reflect, the issues encoun-
tered in the course of providing the best possible care 
for our patients during a pandemic are multilayered 
and dependent on internal and external factors that 
vary across different cultural, legislative, economical and 
geographical areas. Moreover, these influences are likely 
to be subject to changing directives of changing degrees 
of influence over time. Standardised responses as usually 
provided by policymakers and societal guidelines do not 
consider these manifold factors and their dynamics in 
order to provide the best possible evidence- based medical 
care during a pandemic.31
In such deleterious scenarios where single patient 
groups and countries and continents are affected, the 
current gold standards for guidelines and policies as 
proposed by evidence- based medicine might not be 
applicable, and even cause negative effects on specific 
subgroups. Carefully graded stages considering legisla-
tive, economical and cultural differences need to set the 
framework for guiding patient care in accordance with 
increasing knowledge of an emerging evidence base. 
Policymakers and healthcare providers must maintain 
awareness of newly emerging influence factors, espe-
cially if readily fit into the subcategories communica-
tion, legislation, environmental/social, while sustaining 
flexibility to respond to the capability, opportunity and/
or motivation for change. These graded stages should 
be selected in accordance with current events, individu-
ally applied in different geographical, economical and 
cultural subspaces and continuously re- evaluated with 
progression of time and events. Therefore, continuous 
and regular multilayered reassessment of the most mean-
ingful domains is necessary.31
The major strength of this study lies in its being the 
first to evaluate the most important drivers of behaviours 
conducive to counteracting the COVID-19 pandemic 
during the first week of public curfews. During this time, 
we applied an accepted model of behavioural change (the 
COM- B model and BCW) to explore a unique snapshot of 
14 paediatric dialysis centres in 12 European countries 
with case loads ranging from 4 to 680 infected patients 
per million. The strength of our novel study approach 
may also inherently limit the interpretation of our results 
due to the absence of comparable studies with which 
to compare. The interpretation of this study’s results is 
further limited by a small number of participating centres 
representative of paediatric dialysis, but perhaps not 
equally representative of other medical responses to the 
COVID-19 pandemic. In addition, the number of partic-
ipants per centre was limited to one clinician only in 
order to facilitate rapid communication and data acqui-
sition. However, given the small number of participants 
and exploratory mixed methods character of this study, 
statistical tests and their corresponding p values should 
be interpreted with caution. Moreover, local case loads 
of the surveyed centres may not reflect overall disease 
burdens of the respective countries and/or other medical 
specialties, with higher numbers of infections and/or 
patients at risk.
Countermeasures evaluated in this study most likely 
reflect similar countermeasures in other medical special-
ties, as current mitigating approaches to COVID-19 all 
rely on the same measures, such as physical distancing, 
PPE and testing capacities.
This study may also serve as a basic framework for 
research and awareness of factors influencing exit strat-
egies for the implemented countermeasures, providing 
clinicians and policymakers with guidelines for early and 
structured adaptation to changing or fluctuating condi-
tions. Ruktanonchai et al32 underline the importance of 
such guidelines in their modelling study which shows that 
relaxation of countermeasures by one country before 
others do so could lead to disease resurgence across 
Europe about 5 weeks earlier than otherwise. Their study 
also highlights the importance of key countries, such as 
France, Germany, Italy and Poland, in continental resur-
gence of disease due to heterogeneous approaches to 
mobility restriction.32
Nevertheless, heterogeneity of countermeasure imple-
mentation can be expected to continue among Euro-
pean centres until ongoing ‘catch- up implementation’ 
saturates response rates, as limited by local availability 
and resources. Although our study provides no solu-
tions to that problem, our ‘mechanistic’ work does 
provide a mirror for the weak evidence basis underlying 
current practice patterns.1 Understanding limitations of 
current approaches to selection and implementation of 
COVID-19 countermeasures might help reassess those 
practices with open minds, allowing rapid ‘institutional 
behavior changes’ in response to emerging evidence on 
efficacy from controlled clinical trials. These will also 
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provide evidence- based knowledge to optimise non- 
medical interventions during the COVID-19 pandemic.
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